Upper-airway cough syndrome with latent eosinophilic bronchitis.
Upper-airway cough syndrome often coexists with other diseases that elicit chronic cough. However, the concomitant conditions are not always relevant to chronic cough, which complicates the cause diagnosis of chronic cough. The objective of this study was to explore the diagnosis and clinical implication of upper-airway cough syndrome with latent eosinophilic bronchitis. Eleven patients with upper-airway cough syndrome and latent eosinophilic bronchitis were retrospectively analyzed for their clinical manifestations, changes of eosinophilia in induced sputum, and cough threshold with capsaicin defined as capsaicin concentration that elicits two or more coughs (C2) and five or more coughs (C5) between pretreatment and post-treatment. All patients reported a history of allergic rhinitis, showed persistent dry cough or small amounts of viscid sputum with a time course of 2-60 months (median = 7 months), and presented with symptoms and signs of rhinitis, normal lung function, and airway responsiveness. Initial eosinophil percentage in induced sputum was 3.5-8.0%. Cough disappeared after 2-5 (3 +/- 1) weeks of only oral antihistamine. With successful treatment, cough threshold C2 increased from 1.73 +/- 1.45 to 4.43 +/- 4.50 micromol/L (t = 2.64, P = 0.025) and C5 increased from 2.79 +/- 2.16 to 10.10 +/- 8.22 micromol/L (t = 3.10, P = 0.011). However, there was no significant change of eosinophil percentage in induced sputum (4.8 +/- 1.5% vs. 4.4 +/- 1.4%, t = 0.84, P = 0.427). Upper-airway cough syndrome with latent eosinophilic bronchitis is a unique condition. The recognition of the entity may avoid unnecessary use of corticosteroids.
Department of Respiratory Medicine, Tongji Hospital, School of Medicine, Tongji University, No. 389 Xincun Road, 200065, Shanghai, China.
Li
L
Yu
Weili
W
Wei
Lan
L
Wang
Yang
Y
Huang
Cuiqin
C
Shi
Hanjing
H
Lü
Zhongmin
Z
Qiu
D000284:Administration, Oral; D000328:Adult; D001991:Bronchitis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D002211:Capsaicin; D003371:Cough / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D003937:Diagnosis, Differential; D003951:Diagnostic Errors / Q000517:prevention & control; D005260:Female; D006633:Histamine Antagonists / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D011657:Pulmonary Eosinophilia / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D012129:Respiratory Function Tests; D012189:Retrospective Studies; D013183:Sputum / Q000166:cytology; D013577:Syndrome; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
D006633:Histamine Antagonists; D002211:Capsaicin